SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 146 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2017. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,000 | -93.7% | 78,824 | -6.1% | 0.00% | – |
| Q3 2018 | $143,000 | +11.7% | 83,940 | +14.5% | 0.00% | – |
| Q2 2018 | $128,000 | -5.2% | 73,304 | -0.2% | 0.00% | – |
| Q1 2018 | $135,000 | -15.6% | 73,453 | +2.1% | 0.00% | – |
| Q4 2017 | $160,000 | +56.9% | 71,964 | +104.5% | 0.00% | – |
| Q3 2017 | $102,000 | -44.9% | 35,189 | -15.2% | 0.00% | – |
| Q2 2017 | $185,000 | +6.3% | 41,507 | +11.2% | 0.00% | – |
| Q1 2017 | $174,000 | -13.4% | 37,343 | +12.9% | 0.00% | – |
| Q4 2016 | $201,000 | +12.3% | 33,076 | +2.0% | 0.00% | – |
| Q3 2016 | $179,000 | +47.9% | 32,427 | +1.6% | 0.00% | – |
| Q2 2016 | $121,000 | +152.1% | 31,927 | +82.4% | 0.00% | – |
| Q1 2016 | $48,000 | -50.0% | 17,505 | +3.4% | 0.00% | – |
| Q4 2015 | $96,000 | +6.7% | 16,927 | 0.0% | 0.00% | – |
| Q3 2015 | $90,000 | -28.0% | 16,927 | +12.0% | 0.00% | – |
| Q2 2015 | $125,000 | – | 15,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,200,000 | $6,072,000 | 2.38% |
| GREAT POINT PARTNERS LLC | 2,175,000 | $6,003,000 | 2.15% |
| Belmont Global Advisors, Inc. | 400,000 | $1,104,000 | 1.12% |
| Trellus Management Company, LLC | 162,900 | $450,000 | 0.78% |
| PURA VIDA INVESTMENTS, LLC | 572,800 | $1,581,000 | 0.72% |
| DAFNA Capital Management LLC | 294,563 | $813,000 | 0.70% |
| Twin Securities, Inc. | 1,687,115 | $4,656,000 | 0.58% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $2,760,000 | 0.33% |
| WALL STREET ASSOCIATES | 269,300 | $743,000 | 0.31% |
| Paulson & Co. | 11,090,000 | $30,608,000 | 0.23% |